Apparent founder effect during the early years of the San Francisco HIV type 1 epidemic (1978-1979)

AIDS Research and Human Retroviruses

Volumn 16, Issue 15, 2000, Pages 1463-1469

  Foley, B ^a   Pan, H ^b   Buchbinder, S ^c   Delwart, E L ^b,d,e  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c AIDS Office San Francisco   (United States)

^d Blood Centers of the Pacific   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE; VIRUS ENVELOPE PROTEIN;

CONFERENCE PAPER; CONTROLLED STUDY; GENE MAPPING; GENE SEQUENCE; GENETIC DISTANCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SERODIAGNOSIS; UNINDEXED SEQUENCE; VACCINE PRODUCTION;

AIDS VACCINES; BASE SEQUENCE; DNA, VIRAL; DRUG DESIGN; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PHYLOGENY; SAN FRANCISCO; VARIATION (GENETICS);

EID: 0034633731     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200750005985     Document Type: Conference Paper

References (45)

1. Presence of human immunodeficiency virus (HIV) type 1 subtype A infection in a New York community with high HIV prevalence
2. Detection of diverse HIV-1 genetic subtypes in the USA
3. Tenth anniversary perspectives on AIDS. HIV: Between past and future
4. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant
5. An HIV type 1 epidemic among injecting drug users in the former Soviet Union caused by a homogeneous subtype A strain
6. Genetic relationships determined by a heteroduplex mobility assay: Analysis of HIV env genes
7. Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses
8. Extreme founder effect in an HIV type 1 subtype A epidemic among drug users in Svetlogorsk, Belarus
9. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand
10. Incubation period of AIDS in San Francisco
11. Estimating AIDS infection rates in the San Francisco cohort
12. Role of primary infection in epidemics of HIV infection in gay cohorts
13. Acquired immune deficiency syndrome (AIDS) trends in the United States, 1978-1982
14. Rapid and simple method for purification of nucleic acids
15. Rapid, transient changes at the env locus of plasma HIV-1 populations during the emergence of protease inhibitor resistance
16. Rapid genetic characterization of HIV-1 from four WHO-sponsored vaccine evaluation sites using a heteroduplex mobility assay
17. Genetic subtyping of human immunodeficiency virus using a heteroduplex mobility assay
18. Genetic heterogeneity of HIV type 1 in Russia: Identification of H variants and relationship with epidemiological data
19. Presence of multiple non-B subtypes and divergent subtype B strains of HIV-1 in individuals infected after overseas deployment
20. Multiple alignments using hidden Markov models
21. PHYLIP - Phylogeny inference package
22. Pattern-induced multi-sequence alignment (PIMA) algorithm employing secondary structure-dependent gap penalties for comparative protein modelling
23. Performance evaluation of amino acid substitution matrices
24. Couse of HIV-1 infection in a cohort of homosexual and bisexual men: An 11 year follow up study
25. A new classification for HIV-1
26. Phenotype associated sequence variation in the third variable domain (V3) of the HIV-1 gp120 molecule
27. V3 loop of the human immunodeficiency virus type 1 Env protein: Interpreting sequence variability
28. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection
29. The molecular clock of HIV-1 unveiled through analysis of a known transmission history
30. The future of human immunodeficiency virus
31. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic
32. Limitations of a molecular clock applied to consideration of the origin of HIV-1
33. Increasing antigenic and genetic diversity of the HIV-1 V3 domain in the course of the AIDS epidemic
34. Epidemiology of human immunodeficiency virus type 1 infection among homosexual men participating in hepatitis B vaccine trials in Amsterdam, New York City, and San Francisco, 1978-1990
35. Inter- and intraclade neutralization of human immunodeficiency virus type 1: Genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes
36. Two antigenetically distinct subtypes of H1V-1: Viral genotype predicts neutralization serotype
37. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: Lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement
38. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera
39. Autologous HIV-1 neutralizing antibodies: Emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies
40. Mechanisms of human immunodeficiency virus type 1 (HIV-1) neutralization: Irreversible inactivation of infectivity by anti-HIV-1 antibody
41. Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus
42. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage